Compensation 990
OrganizationsEmployeesBoard MembersGrantsContractorsTop RankingsPricing

Stay updated on 990 organization compensation

© Civic Register LLC

Compensation 990 is an independent service that uses public IRS Form 990 filings as its source data. We clean and standardize this information, but the original filings may contain errors or omissions. Years on this site refer to the organization’s fiscal year end date on the filing.

About•Report a discrepancy•Your privacy choices
Organizations Health Care Bio Ventures For Global Health

Bio Ventures For Global Health

Fiscal year ending 2024. Filed on November 14, 2025.

2101 Fourth Ave 1950
Seattle, Washington 98121

Bio Ventures For Global Health (EIN: 30-0213137) has filed an IRS Form 990 between fiscal years 2016 and 2024. In its fiscal year 2024 IRS Form 990 filing, Bio Ventures For Global Health, a 501(c)(3) charitable organization, reported compensation for 3 out of 18 total employees. Among the employees shown here, the average compensation is $294,383. The highest compensated employee at Bio Ventures For Global Health is Jennifer Dent with fiscal year 2024 compensation of $486,109.

Revenue, expenses, and employee compensation

Revenue

$504,858

Expenses

$2,591,563

Employee compensation

$2,141,244
Revenue, expenses, and employee compensation over time

Reported Compensated Employees

Jennifer Dent
President and Chief Executive Officer
$486,109
$433,705 No related comp$52,404
Katy Graef
Vice President, Programs
$208,226
$190,233 No related comp$17,993
Cathyryne Manner
Vice President
$188,815
$170,208 No related comp$18,607

Benchmark Employee Compensation

Non-Employee Board Members

Belinda Termeer
Director
Dr Julie Gralow
Director
J Leighton Read, M.D.
Director
Jim Geraghty
Chair
John Nevergole
Director
Rachel King
Director
Ruth Atherton
Director
Seringe Magueye Gueye
Director

Mission Statement

BVGH drives sustainable, market-informed solutions to improve access to quality healthcare in low- and middle-income countries. BVGH builds cross-sector partnerships that align industry, government, and local health-system priorities to expand access to cancer care, infectious disease technologies, and essential medicines. BVGHs flagship programs focus on strengthening cancer and infectious disease ecosystems through coordinated national strategies, capacity building, and responsible product introduction. Key activities include the African Access Initiative (AAI), which supports countries in developing cancer control plans, expanding diagnostics and treatment capacity, and improving affordability and availability of oncology products. BVGH also brokers collaborations between companies and African research institutions to advance R&D, clinical trials, workforce training, and technology transfer. These activities collectively enhance health-system readiness, accelerate access to lifesavi

Revisions to this organization profile

November 14, 2025:
2024 Bio Ventures For Global Health 990 filed
November 15, 2024:
2023 Bio Ventures For Global Health 990 filed
November 15, 2023:
2022 Bio Ventures For Global Health 990 filed

Get an email when new compensation information is released for Bio Ventures For Global Health

Be the first to know when new IRS Form 990 data is published for this organization.

Related Jobs

View more jobs
Powered by Talroo
Report a discrepancy →